These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29749488)

  • 1. C‑Myc inhibitor 10058‑F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells.
    Lv M; Wang Y; Wu W; Yang S; Zhu H; Hu B; Chen Y; Shi C; Zhang Y; Mu Q; Ouyang G
    Mol Med Rep; 2018 Jul; 18(1):421-428. PubMed ID: 29749488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Aiolos in Nalm-6 acute lymphoblastic leukaemia cells reduces apoptosis by suppressing phosphatase and tensin homologue deleted on chromosome 10 and activating the phosphatidylinositol-3-kinase/Akt signalling pathway.
    Wang R; Guo G; Li H; Li X; Yu Y; Li D
    Mol Med Rep; 2015 May; 11(5):3457-64. PubMed ID: 25608224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
    Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
    Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc promotes tumor proliferation and anti‑apoptosis by repressing p21 in rhabdomyosarcomas.
    Zhang J; Song N; Zang D; Yu J; Li J; Di W; Guo R; Zhao W; Wang H
    Mol Med Rep; 2017 Oct; 16(4):4089-4094. PubMed ID: 28765944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
    Medh RD; Wang A; Zhou F; Thompson EB
    Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells.
    Noh EJ; Kang SW; Shin YJ; Choi SH; Kim CG; Park IS; Wheatley DN; Min BH
    Int J Cancer; 2004 Nov; 112(3):502-8. PubMed ID: 15382078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
    Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
    J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
    Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
    J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beating the Clock in T-cell Acute Lymphoblastic Leukemia.
    Carroll WL; Aifantis I; Raetz E
    Clin Cancer Res; 2017 Feb; 23(4):873-875. PubMed ID: 28007775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.
    Pikman Y; Alexe G; Roti G; Conway AS; Furman A; Lee ES; Place AE; Kim S; Saran C; Modiste R; Weinstock DM; Harris M; Kung AL; Silverman LB; Stegmaier K
    Clin Cancer Res; 2017 Feb; 23(4):1012-1024. PubMed ID: 28151717
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells.
    Carlet M; Janjetovic K; Rainer J; Schmidt S; Panzer-Grümayer R; Mann G; Prelog M; Meister B; Ploner C; Kofler R
    BMC Cancer; 2010 Nov; 10():638. PubMed ID: 21092265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
    Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
    Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
    Wang XW; Xu YH
    Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
    Bhadri VA; Trahair TN; Lock RB
    J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.
    Li Y; Deutzmann A; Choi PS; Fan AC; Felsher DW
    Oncotarget; 2016 May; 7(19):26926-34. PubMed ID: 27095570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.